10320EGP
- Active ingredient
- rituximab
- Strength
- 500 mg/50ml
- Form
- vial
- Manufacturer
- f.hoffman la roche > memphis
- Route
- injection
Uses
Used in certain B-cell non-Hodgkin lymphomas and other CD20-positive disorders. May be used alone or with chemotherapy depending on the condition.
Do not use if
No specific absolute contraindications are listed, but hypersensitivity requires caution.
Side effects
Infusion-related reactions, infections, fever, fatigue, and skin reactions may occur. Serious viral reactivation can occur.
Warnings
Monitor for severe skin reactions, hepatitis B reactivation, progressive multifocal leukoencephalopathy, and serious infections.
How it works
Monoclonal antibody targeting CD20 on B lymphocytes, leading to B-cell depletion.
Storage
Store refrigerated at 2–8°C and protect from light. Do not freeze.
